Anthony C. Faber

Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition

Aaron N. Hata, Matthew J. Niederst, Hannah L. Archibald et al. · Nature Medicine · 2016 · 999 citations · Full text

Medicine, Cancer Biology, Oncology +15

Patient-derived models of acquired resistance can identify effective drug combinations for cancer

Adam Crystal, Alice T. Shaw, Lecia V. Sequist et al. · Science · 2014 · 733 citations

Medicine, Oncology, Pharmacology +17

Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins

Marta Guix, Anthony C. Faber, Shizhen Emily Wang et al. · Journal of Clinical Investigation · 2008 · 522 citations · Full text

Medicine, Oncology, Pharmacology +17

Synthetic Lethal Interaction of Combined BCL-XL and MEK Inhibition Promotes Tumor Regressions in KRAS Mutant Cancer Models

Ryan B. Corcoran, Katherine A. Cheng, Aaron N. Hata et al. · Cancer Cell · 2012 · 379 citations · Full text

Medicine, Cancer Biology, Oncology +17

Differential induction of apoptosis in HER2 and EGFR addicted cancers following PI3K inhibition

Anthony C. Faber, Danan Li, Young-Chul Song et al. · Proceedings of the National Academy of Sciences · 2009 · 320 citations · Full text

Life Sciences, Oncology, Pharmacology +17